Alnylam Pharmaceuticals (ALNY) Other financing activities (as filed) (2012 - 2026)
Alnylam Pharmaceuticals (ALNY) recorded Other financing activities (as filed) of -$6,000 in Q2 2026.
Powered by 
Analysis
Alnylam Pharmaceuticals (ALNY) Other financing activities (as filed) (2012 - 2026) Analysis & Trends
On a TTM basis, Alnylam Pharmaceuticals' Other financing activities (as filed) came in at -$2.43 million as of Jun 30, 2026; for FY2025, it came in at -$2.41 million.
- Across earlier years, Other financing activities (as filed) came in at -$8.79 million in FY2024, $24.67 million in FY2023, -$87.61 million in FY2022 and $19.6 million in FY2021 (+133.3%).
- Quarterly Other financing activities (as filed) has ranged from -$67.24 million in Q3 2025 to $118.61 million in Q3 2022 over the past five years.
- Peak year-over-year performance for Other financing activities (as filed) in the last five years was growth of 281.0% in Q4 2021, against a decline of 93.0% in Q3 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at -$9,000 (Q1 2026), $64.82 million (Q4 2025) and -$67.24 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Alnylam Pharmaceuticals | 20.30 Bn | 7.49 Bn | 1.10 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -6,000.00 |
| Mar 31, 2026 | -9,000.00 |
| Sep 30, 2025 | -39.15 Mn |
| Dec 31, 2024 | -5.28 Mn |
| Jun 30, 2024 | -1.28 Mn |
| Mar 31, 2024 | 3.05 Mn |
| Dec 31, 2023 | 8.33 Mn |
| Sep 30, 2023 | 8.33 Mn |
| Jun 30, 2023 | 4.00 Mn |
| Mar 31, 2023 | 4.00 Mn |
| Dec 31, 2022 | 7.50 Mn |
| Sep 30, 2022 | 118.61 Mn |
| Jun 30, 2022 | 7.83 Mn |
| Mar 31, 2022 | 7.83 Mn |
| Dec 31, 2021 | 16.00 Mn |
| Sep 30, 2021 | 1.45 Mn |
| Jun 30, 2021 | -2.05 Mn |
| Mar 31, 2021 | 4.20 Mn |
| Dec 31, 2020 | 4.20 Mn |
| Sep 30, 2020 | 4.20 Mn |
API Access
Alnylam Pharmaceuticals Other financing activities (as filed) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-financing-activities&ticker=ALNY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-financing-activities", "ticker": "ALNY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-financing-activities&ticker=ALNY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();